V. Kettmann et J. Svetlik, (6R*,16R*)-9,14-dihydro-6-methyl-6,16-methano-6H,16H-[2,4]benzothiazepino[3,4-d][1,3,5]benzoxadi-azocine hydrobromide dimethylformamide hemisolvate, ACT CRYST C, 56, 2000, pp. 1115-1116
The title compound, C19H19N2OS+. Br-. 0.5C(3)H(7)NO, is an oxygen-bridged p
henylpyrimidine derivative in which the heterocyclic ring is protonated, th
e positive charge being dispersed over both of the N atoms. Both molecules
in the asymmetric unit exist in an identical conformation, which consists o
f a central planar portion with the two terminal phenyl rings protruding fr
om the same side of the plane. One of the independent molecules forms a str
ong hydrogen bond with the bromide anion, while the other is hydrogen bonde
d to the dimethylformamide solvent molecule.